|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL.: (2006.01) |
A61K 31/415 C07D 231/00 C07D 257/00 C07D 277/00 C07D 401/00 C07D 403/00 C07D 413/00 C07D 417/00 C07D 487/00 |
| (11) | Number of the document | 4702 |
| (13) | Kind of document | B |
| (21) | Application number | 99-146 |
| (22) | Date of filing the application | 1999-12-17 |
| (41) | Date of publication of the application | 2000-05-25 |
| (45) | Date of publication of patent | 2000-09-25 |
| (86) | Number | PCT/US98/12681 |
| Date | 1998-06-18 |
| (87) | Number | WO 98/57937 |
| Date | 1998-12-23 |
| (30) | Number | Date | Country code |
| 878885 | 1997-06-19 | US | |
| 076691 | 1998-02-27 | US |
| (71) |
DUPONT PHARMACEUTICALS COMPANY,
1007 Market Street, Wilmington, Delaware 19898,
US
|
| (72) |
Anthony Robert Jr. GALEMMO, US
Celia DOMINGUEZ, US John Matthew FEVIG, US Qi HAN, US Yuk-Sun Patrick LAM, US Donald Joseph Phillip PINTO, US James Russell PRUITT, US Mimi Lifen QUAN, US |
| (73) |
DUPONT PHARMACEUTICALS COMPANY,
1007 Market Street, Wilmington, Delaware 19898,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP |
| Payment date | Validity (years) | Amount | |
| 2001-05-30 | 4 | 320.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2002-06-18 |